Healthcare
ByRegeneron to Present at 44th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Is Tanya Alcorn Poised to Transform Pfizer’s Global Hospital and Biosimilars Strategy?
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities after serving more…
Is Pfizer Facing New Safety Scrutiny After Reporting a Patient Death in Its Hympavzi Hemophilia Trial?
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia treatment Hympavzi died…
Will Agios Pharma’s FDA Approval Expansion Drive a New Growth Phase in Blood Disorder Treatment?
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the U.S. Food and…
Novartis Builds on a Track Record of Expansion Ahead of the 2026 J.P. Morgan Healthcare Conference
Basel, Switzerland Novartis closed 2025 with sustained operational momentum, building on its transformation into a pure-play innovative medicines…
